John A. Lewicki
CIK 1553352 · Chief Scientific Officer · last filed 2026-02-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$28.3K
Companies
1
Total Filings
39
Lifetime Open-Market Net
-$153.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MREO | Chief Scientific Officer | 92,826 | $0.30 | $28.3K | -$153.9K | 7 | 2026-02-02 |
Recent Filings · Page 2 of 4
39 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-04-26 | — | Sell (S) | −4,557 | -$12.2K | |
| 2018-03-19 | — | Grant (A) | — | $0 | |
| 2018-02-23 | — | Grant (A) | — | $0 | |
| 2018-01-08 | — | Grant (A) | — | $0 | |
| 2017-10-12 | — | Sell (S) | −1,248 | -$5.3K | |
| 2017-10-10 | — | Grant (A) | +25,000 | $0 | |
| 2017-04-25 | — | Grant (A) | +22,500 | $0 | |
| 2017-04-05 | — | Sell (S) | −5,754 | -$52.1K | |
| 2017-01-05 | — | Mixed | — | -$56.9K | |
| 2016-10-11 | — | Grant (A) | +12,500 | $0 |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.